| Date | Time | Source | Headline | Symbol | Company |
| 14/02/2014 | 20:15 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 10/10/2013 | 20:54 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 23/09/2013 | 14:35 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 17/09/2013 | 11:00 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 17/09/2013 | 11:00 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 23:25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 23:24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 23:23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 23:22 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 23:20 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 23:20 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 21:03 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 21:03 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 21:02 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 21:02 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 21:02 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 21:02 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 21:02 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 13/09/2013 | 21:01 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 11/09/2013 | 22:11 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 11/09/2013 | 22:10 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 11/09/2013 | 22:08 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 11/09/2013 | 21:30 | Business Wire | Cubist Pharmaceuticals Completes Acquisition of Trius Therapeutics | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 11/09/2013 | 21:30 | Business Wire | Cubist Pharmaceuticals Completes Acquisition of Trius Therapeutics | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 11/09/2013 | 21:26 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 11/09/2013 | 16:00 | Business Wire | Cubist Pharmaceuticals Announces Results of Tender Offer for Outstanding Shares of Trius Therapeutics | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 11/09/2013 | 16:00 | Business Wire | Cubist Pharmaceuticals Announces Results of Tender Offer for Outstanding Shares of Trius Therapeutics | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 06/09/2013 | 21:01 | GlobeNewswire Inc. | Trius Therapeutics to Present Data From Antibiotics Development Programs at ICAAC 2013 | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 05/09/2013 | 21:51 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |
| 05/09/2013 | 21:46 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:TSRX | Trius Therapeutics, Inc. (MM) |